2026 Campus Program – 医药推广 at Eli Lilly and Company

Shanghai, Shanghai, China

Eli Lilly and Company Logo
Not SpecifiedCompensation
Internship, Entry Level & New GradExperience Level
InternshipJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

  • 全日制本科或以上学历的2025年应届毕业生。
  • 优先考虑生物科学、制药工程、药事管理等药学相关专业或与制药相关的商科专业。
  • 优先考虑有医药行业相关实习或有在高校组织担任干事经验的学生。
  • 拥有良好的沟通能力和学习能力。
  • 具备积极向上的心态和勇于挑战的韧性。
  • 确保实习期至少3个月。

Responsibilities

  • 专业知识学习:掌握包括但不限于礼来公司和医药行业相关信息、基础产品和合规知识、学术推广技巧等内容。
  • 推广技能提升:跟随地区经理和带教师傅建立与区域客户的有效沟通,通过专业的学术推广向客户提供解决方案,在实习期间不设有业务指标。
  • 跨部门合作:协调内外跨团队资源,参与区域市场项目的执行与实施。

Skills

Pharmaceutical Knowledge
Product Promotion
Academic Promotion
Compliance Knowledge
Client Communication
Market Project Execution
Cross-functional Collaboration
Communication Skills

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI